Embed this press release by copying the code below:
NASDAQ:RARE Shareholder Notice: Investigation over Potential Wrongdoing at Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE Shareholder Notice: Investigation over Potential Wrongdoing at Ultragenyx Pharmaceutical Inc.